EEF2K and Alzheimer disease: Genetic or pharmacological targeting of eEF2K in AD or PD cultured neurons, Caenorhabditiselegans or mouse models (Ma et al., 2014) restores normal electrophysiology and even reverses disease-associated behavioural defects (Ma et al., 2014; Jan et al., 2018; Jan et al., 2017).